U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Substance Class Protein
Created
by admin
on Sat Dec 16 13:11:17 GMT 2023
Edited
by admin
on Sat Dec 16 13:11:17 GMT 2023
Protein Type BISPECIFIC ANTIBODY
Protein Sub Type IMMUNOMODULATOR
Sequence Origin HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
42HQ15W1ZF
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
TIBULIZUMAB
INN   USAN  
Official Name English
TIBULIZUMAB [USAN]
Common Name English
LY3090106
Code English
IMMUNOGLOBULIN, BISPECIFIC TETRAVALENT, ANTI-(HUMAN B-CELL ACTIVATING FACTOR OF THE TUMOR NECROSIS FACTOR FAMILY/HUMAN INTERLEUKIN 17) HEAVY CHAIN, DISULFIDE WITH ANTI-(B-CELL ACTIVATING FACTOR OF THE TUMOR NECROSIS FACTOR FAMILY) LIGHT CHAIN, DIMER
Common Name English
tibulizumab [INN]
Common Name English
LY-3090106
Code English
Classification Tree Code System Code
NCI_THESAURUS C20401
Created by admin on Sat Dec 16 13:11:17 GMT 2023 , Edited by admin on Sat Dec 16 13:11:17 GMT 2023
Code System Code Type Description
INN
10656
Created by admin on Sat Dec 16 13:11:17 GMT 2023 , Edited by admin on Sat Dec 16 13:11:17 GMT 2023
PRIMARY
FDA UNII
42HQ15W1ZF
Created by admin on Sat Dec 16 13:11:17 GMT 2023 , Edited by admin on Sat Dec 16 13:11:17 GMT 2023
PRIMARY
CAS
1849636-24-3
Created by admin on Sat Dec 16 13:11:17 GMT 2023 , Edited by admin on Sat Dec 16 13:11:17 GMT 2023
PRIMARY
DRUG BANK
DB14848
Created by admin on Sat Dec 16 13:11:17 GMT 2023 , Edited by admin on Sat Dec 16 13:11:17 GMT 2023
PRIMARY
NCI_THESAURUS
C152608
Created by admin on Sat Dec 16 13:11:17 GMT 2023 , Edited by admin on Sat Dec 16 13:11:17 GMT 2023
PRIMARY
USAN
DE-86
Created by admin on Sat Dec 16 13:11:17 GMT 2023 , Edited by admin on Sat Dec 16 13:11:17 GMT 2023
PRIMARY
From To
1_22 1_95
1_137 3_214
1_150 1_206
1_229 2_229
1_232 2_232
1_264 1_324
1_370 1_428
2_22 2_95
2_137 4_214
2_150 2_206
2_264 2_324
2_370 2_428
2_485 2_559
2_507 2_707
2_625 2_695
3_23 3_88
3_134 3_194
4_23 4_88
4_134 4_194
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_300
N 2_300
Related Record Type Details
TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13B MEMBRANE FORM
TARGET -> INHIBITOR
INTERLEUKIN-17A
TARGET -> INHIBITOR
Related Record Type Details
TIBULIZUMAB
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966